During the past decade, Selma Medical Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Selma Medical Associates" #1 sponsor was "American Regent, Inc." with 1 trials, followed by "Amgen" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Selma Medical Associates" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Selma Medical Associates" are "Heart Failure" (2 trials), "Cardiovascular Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "High Cardiovascular Risk" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "Selma Medical Associates" in a lesser frequency.

Most popular intervention types in "Selma Medical Associates" are "Drug" (5 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Evolocumab" (1 trials), "ExPEC9V" (1 trials) and "Ferric Carboxymaltose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Selma Medical Associates" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Selma Medical Associates". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Selma Medical Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Selma Medical Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".